###begin article-title 0
Developmental Context Determines Latency of MYC-Induced Tumorigenesis
###end article-title 0
###begin article-title 1
Developmental Milieu Influences a Gene's Role in Tumor Formation
###end article-title 1
###begin p 2
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-MYC</italic>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 919 922 919 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1077 1080 1077 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 383 398 <span type="species:ncbi:10090">transgenic mice</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 484 490 <span type="species:ncbi:10090">murine</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 837 841 <span type="species:ncbi:10090">mice</span>
One of the enigmas in tumor biology is that different types of cancers are prevalent in different age groups. One possible explanation is that the ability of a specific oncogene to cause tumorigenesis in a particular cell type depends on epigenetic parameters such as the developmental context. To address this hypothesis, we have used the tetracycline regulatory system to generate transgenic mice in which the expression of a c-MYC human transgene can be conditionally regulated in murine hepatocytes. MYC's ability to induce tumorigenesis was dependent upon developmental context. In embryonic and neonatal mice, MYC overexpression in the liver induced marked cell proliferation and immediate onset of neoplasia. In contrast, in adult mice MYC overexpression induced cell growth and DNA replication without mitotic cell division, and mice succumbed to neoplasia only after a prolonged latency. In adult hepatocytes, MYC activation failed to induce cell division, which was at least in part mediated through the activation of p53. Surprisingly, apoptosis is not a barrier to MYC inducing tumorigenesis. The ability of oncogenes to induce tumorigenesis may be generally restrained by developmentally specific mechanisms. Adult somatic cells have evolved mechanisms to prevent individual oncogenes from initiating cellular growth, DNA replication, and mitotic cellular division alone, thereby preventing any single genetic event from inducing tumorigenesis.
###end p 2
###begin p 3
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
###xml 121 129 <span type="species:ncbi:9606">children</span>
A transgenic mouse model demonstrates that developmental context may be the reason why the spectrum of tumors differs in children and adults
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 470 482 470 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Greaves1">Greaves 1986</xref>
###xml 484 504 484 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Klein1">Klein and Klein 1986</xref>
###xml 625 642 625 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Adams1">Adams et al. 1985</xref>
###xml 644 667 644 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Spanopoulou1">Spanopoulou et al. 1989</xref>
###xml 669 691 669 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris1">Pelengaris et al. 1999</xref>
###xml 693 710 693 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Blyth1">Blyth et al. 2000</xref>
###xml 80 86 <span type="species:ncbi:9606">humans</span>
The frequency of cancer development varies depending on the age of the host. In humans, the most common childhood cancers include tumors of the hematopoietic system, nervous system, and skeletal muscle system. In contrast, in the adult population, solid tumors of the lung, colon, breast, and prostate are more common. Differences in types of cancers in hosts of different ages may reflect the abundance of cells in a differentiative state susceptible to tumorigenesis (Greaves 1986; Klein and Klein 1986). Indeed, many reports document that oncogene activation generally induces tumorigenesis in immature cellular lineages (Adams et al. 1985; Spanopoulou et al. 1989; Pelengaris et al. 1999; Blyth et al. 2000).
###end p 5
###begin p 6
###xml 206 222 206 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Jain1">Jain et al. 2002</xref>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C-MYC</italic>
###xml 731 736 731 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C-MYC</italic>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
We recently reported that upon oncogene inactivation tumor cells can differentiate into mature cells, and in this new differentiative context the reactivation of an oncogene fails to restore tumorigenesis (Jain et al. 2002). Based on these results, we speculate that only specific differentiative windows provide the correct epigenetic program to permit oncogene activation to initiate and sustain tumorigenesis. Here we directly evaluate whether an oncogene's ability to induce tumorigenesis depends on the differentiative context when this oncogene first becomes activated. We have examined the ability of the C-MYC oncogene to induce tumorigenesis in mice of different ages using a novel conditional transgenic model system for C-MYC-induced hepatocellular carcinoma (HCC).
###end p 6
###begin p 7
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C-MYC</italic>
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 87 98 87 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC, N-MYC,</italic>
###xml 103 113 103 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L-MYC. MYC</italic>
###xml 303 323 303 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Johnston1">Johnston et al. 1999</xref>
###xml 325 345 325 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Grandori1">Grandori et al. 2000</xref>
###xml 347 364 347 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Oster1">Oster et al. 2002</xref>
###xml 366 389 366 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris3">Pelengaris et al. 2002a</xref>
###xml 623 632 623 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Dang1">Dang 1999</xref>
###xml 634 658 634 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher2">Felsher and Bishop 1999a</xref>
###xml 660 680 660 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Grandori1">Grandori et al. 2000</xref>
###xml 682 699 682 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Oster1">Oster et al. 2002</xref>
###xml 701 724 701 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris3">Pelengaris et al. 2002a</xref>
###xml 726 746 726 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Karlsson1">Karlsson et al. 2003</xref>
###xml 894 917 894 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris3">Pelengaris et al. 2002a</xref>
C-MYC (now referred to as MYC) is a member of a family of proto-oncogenes comprising C-MYC, N-MYC, and L-MYC. MYC encodes a transcription factor that, as part of a heterodimeric complex with MAX, regulates the expression of a multitude of genes involved in regulating cellular proliferation and growth (Johnston et al. 1999; Grandori et al. 2000; Oster et al. 2002; Pelengaris et al. 2002a). Overexpression of MYC is commonly associated with tumorigenesis. MYC exerts its neoplastic function by inducing autonomous cellular proliferation and cellular growth, blocking differentiation, and inducing genomic destabilization (Dang 1999; Felsher and Bishop 1999a; Grandori et al. 2000; Oster et al. 2002; Pelengaris et al. 2002a; Karlsson et al. 2003). It is generally assumed that MYC is restrained from causing tumorigenesis because it concomitantly induces cellular proliferation and apoptosis (Pelengaris et al. 2002a).
###end p 7
###begin p 8
###xml 78 107 78 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Thorgeirsson1">Thorgeirsson and Grisham 2002</xref>
###xml 323 352 323 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Thorgeirsson1">Thorgeirsson and Grisham 2002</xref>
###xml 621 638 621 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Chang1">Chang et al. 1991</xref>
###xml 40 45 <span type="species:ncbi:9606">human</span>
HCC is a common and generally incurable human malignancy of epithelial cells (Thorgeirsson and Grisham 2002). HCC has been strongly associated with viral infections such as hepatitis B and C; exposure to toxins, such as alcohol, aflatoxin, and phenobarbital; and exposure to various carcinogens such as polyvinyl chloride (Thorgeirsson and Grisham 2002). Interestingly, the ability of these carcinogens, such as the hepatitis viruses, to induce HCC depends on the host age during infection. Hepatitis B infection acquired during neonatal development versus adulthood results in a several-magnitude increased risk of HCC (Chang et al. 1991). These results suggest that there are differentiative windows during liver development that may be more susceptible to neoplastic transformation.
###end p 8
###begin p 9
###xml 84 102 84 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Buetow1">Buetow et al. 1989</xref>
###xml 104 121 104 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Tsuda1">Tsuda et al. 1990</xref>
###xml 123 140 123 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Boige1">Boige et al. 1997</xref>
###xml 142 158 142 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Piao1">Piao et al. 1997</xref>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 334 357 334 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020332-Elella1">Abou-Elella et al. 1996</xref>
###xml 359 377 359 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kawate1">Kawate et al. 1999</xref>
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 444 467 444 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020332-Elella1">Abou-Elella et al. 1996</xref>
###xml 469 487 469 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kawate1">Kawate et al. 1999</xref>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 591 614 591 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0020332-Elella1">Abou-Elella et al. 1996</xref>
###xml 627 630 627 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 380 385 <span type="species:ncbi:9606">Human</span>
Human tumors have been analyzed extensively for genetic events associated with HCC (Buetow et al. 1989; Tsuda et al. 1990; Boige et al. 1997; Piao et al. 1997). MYC oncogene activation is one of the more common events in the pathogenesis of HCC. MYC overexpression in human HCC is most commonly associated with genomic amplification (Abou-Elella et al. 1996; Kawate et al. 1999). Human HCCs exhibit amplification of MYC in up to 50% of tumors (Abou-Elella et al. 1996; Kawate et al. 1999). The presence of MYC amplification in HCC portends a more advanced and aggressive clinical phenotype (Abou-Elella et al. 1996). Thus, the MYC oncogene appears to play a critical role in the pathogenesis of HCC.
###end p 9
###begin p 10
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 112 132 112 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Sandgren1">Sandgren et al. 1989</xref>
###xml 134 152 134 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Fourel1">Fourel et al. 1990</xref>
###xml 154 174 154 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Murakami1">Murakami et al. 1993</xref>
###xml 176 205 176 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Morgenbesser1">Morgenbesser and DePinho 1994</xref>
###xml 207 226 207 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Sargent1">Sargent et al. 1996</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Sargent2">1999</xref>
###xml 234 255 234 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-De1">De Miglio et al. 1999</xref>
###xml 257 282 257 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Santoni-Rugiu1">Santoni-Rugiu et al. 1999</xref>
###xml 284 302 284 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Renard1">Renard et al. 2000</xref>
###xml 305 308 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 421 439 421 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Fourel1">Fourel et al. 1990</xref>
###xml 441 459 441 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Renard1">Renard et al. 2000</xref>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 557 578 557 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-De1">De Miglio et al. 1999</xref>
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 651 655 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS,</italic>
###xml 705 725 705 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Sandgren1">Sandgren et al. 1989</xref>
###xml 878 898 878 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Murakami1">Murakami et al. 1993</xref>
###xml 900 919 900 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Sargent1">Sargent et al. 1996</xref>
###xml 921 925 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Sargent2">1999</xref>
###xml 927 952 927 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Santoni-Rugiu1">Santoni-Rugiu et al. 1999</xref>
###xml 1002 1005 1002 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 397 406 <span type="species:ncbi:9995">woodchuck</span>
###xml 488 499 <span type="species:ncbi:10116">Wistar rats</span>
###xml 670 676 <span type="species:ncbi:10090">murine</span>
###xml 756 771 <span type="species:ncbi:10090">transgenic mice</span>
The most compelling evidence that MYC is causally associated with the etiology of HCC comes from animal models (Sandgren et al. 1989; Fourel et al. 1990; Murakami et al. 1993; Morgenbesser and DePinho 1994; Sargent et al. 1996, 1999; De Miglio et al. 1999; Santoni-Rugiu et al. 1999; Renard et al. 2000). MYC is frequently activated through insertional mutagenesis mediated by the hepadnavirus in woodchuck liver tumors (Fourel et al. 1990; Renard et al. 2000). Carcinogen-induced HCC in Wistar rats is associated with MYC amplification and overexpression (De Miglio et al. 1999). The overexpression of MYC (as a transgene) and other oncogenes (e.g., RAS, T antigen) in murine hepatocytes results in HCC (Sandgren et al. 1989). The latency of HCC in these transgenic mice is long, but is greatly accelerated by the transgenic overexpression of transforming growth factor-alpha (Murakami et al. 1993; Sargent et al. 1996, 1999; Santoni-Rugiu et al. 1999). These results highlight that the activation of MYC alone is not sufficient to induce HCC.
###end p 10
###begin p 11
###xml 515 539 515 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher3">Felsher and Bishop 1999b</xref>
###xml 571 574 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 804 807 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 387 402 <span type="species:ncbi:10090">transgenic mice</span>
###xml 688 694 <span type="species:ncbi:10090">murine</span>
Traditional transgenic systems that have been previously used to study the role of oncogenes in tumorigenesis continuously overexpress transgenes and hence preclude the investigation of the initial and developmentally specific consequences of oncogene activation. To investigate the developmentally specific consequences of MYC overexpression in the pathogenesis of HCC in vivo, we used transgenic mice in which the MYC proto-oncogene is conditionally regulated via the tetracycline regulatory system (Tet system) (Felsher and Bishop 1999b). We found that the ability of MYC to induce cellular proliferation versus cellular growth, and consequently its ability to induce tumorigenesis in murine hepatocytes, was dependent on the age of the host. Our results have implications for the mechanisms by which MYC and other oncogenes initiate and are restrained from causing tumorigenesis.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
A Conditional Model System for MYC-Induced HCC
###end title 13
###begin p 14
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 75 94 75 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kistner1">Kistner et al. 1996</xref>
###xml 96 120 96 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher3">Felsher and Bishop 1999b</xref>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 161 185 161 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher3">Felsher and Bishop 1999b</xref>
###xml 259 262 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 298 301 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 303 322 303 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kistner1">Kistner et al. 1996</xref>
###xml 508 511 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 544 552 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">Figure 1</xref>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 756 759 756 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 895 898 895 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 55 61 <span type="species:ncbi:10090">murine</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 438 442 <span type="species:ncbi:10090">Mice</span>
###xml 556 560 <span type="species:ncbi:10090">Mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 913 919 <span type="species:ncbi:10090">murine</span>
We used the Tet system to conditionally express MYC in murine hepatocytes (Kistner et al. 1996; Felsher and Bishop 1999b). We mated the transgenic line TRE-MYC (Felsher and Bishop 1999b), which contains the tetracycline response element adjacent to the human MYC cDNA, with the transgenic line LAP-tTA (Kistner et al. 1996), which contains a liver-specific enhancer that drives the expression of the tetracycline-transactivating protein. Mice possessing both transgenes exhibited increased expression of the MYC transgene in their hepatocytes (Figure 1A). Mice possessing either transgene alone did not overexpress MYC and lacked evidence of morbidity or mortality. Similarly, mice possessing both transgenes that were treated with doxycycline to suppress MYC transgene expression did not exhibit a phenotype. Thus, we have developed a transgenic model that enables us to conditionally regulate MYC expression in murine hepatocytes.
###end p 14
###begin p 15
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">Figure 1</xref>
###xml 652 660 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">Figure 1</xref>
###xml 715 723 715 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g002">Figure 2</xref>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g002">2</xref>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
To investigate if MYC overexpression is sufficient to induce HCC in our model system, we removed doxycycline treatment in adult mice (6-12 weeks of age) transgenic for both TRE-MYC and LAP-tTA. Ninety percent of adult mice overexpressing MYC succumbed to liver tumors with a mean latency of 35 weeks. At necropsy, mice exhibited marked gross enlargement of the liver with multiple tumor masses (Figure 1B). The normal liver architecture was disrupted by nodular tumors with histological features typical of HCC. Tumors were composed of dysplastic nests of cells with large pleomorphic nuclei, delicate vesicular chromatin, and very prominent nucleoli (Figure 1C). Tumors could invade into the abdomen and the lung (Figure 2A-2C). These features demonstrated that MYC overexpression in adult mice resulted in HCC.
###end p 15
###begin p 16
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 166 174 166 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">Figure 1</xref>
###xml 269 277 269 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">Figure 1</xref>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">1</xref>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 518 523 <span type="species:ncbi:9606">human</span>
To confirm that these tumors were malignant, we transplanted them subcutaneously into scid mice. Tumors formed in the inoculated mice after an 8-10-week latency (see Figure 1D). The transplanted tumors displayed identical histology to the primary transgenic tumor (see Figure 1E versus 1C). Normal adult hepatocytes failed to induce tumors when inoculated into scid mice. We conclude that MYC overexpression in adult hepatocytes results in the formation of highly malignant liver cancers with features consistent with human HCC.
###end p 16
###begin title 17
Developmental State of the Host Influences on Frequency and Latency of Tumor Onset
###end title 17
###begin p 18
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 312 315 312 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 523 531 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 567 570 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 183 187 <span type="species:ncbi:10090">Mice</span>
###xml 298 302 <span type="species:ncbi:10090">Mice</span>
###xml 389 393 <span type="species:ncbi:10090">Mice</span>
To determine if the developmental state of host hepatocytes influenced the ability of MYC activation to induce tumorigenesis, we induced MYC in cohorts of different ages (Figure 3A). Mice that overexpressed MYC during embryonic development of the liver succumbed to neoplasia within 10 d of birth. Mice in which MYC was activated at birth (neonates) succumbed to neoplasia within 8 weeks. Mice in which MYC was induced at 4 weeks or 6-12 weeks of age developed tumors after a mean latency of 15 and 35 weeks, respectively (Figure 3A). We conclude that the ability of MYC activation to induce tumorigenesis in hepatocytes is inversely correlated with the developmental age of the host.
###end p 18
###begin p 19
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 422 430 422 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 590 593 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 758 766 758 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 859 862 859 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 874 882 874 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 914 917 914 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1034 1037 1034 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1138 1146 1138 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 1278 1281 1278 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1343 1346 1343 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1484 1487 1484 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1657 1660 1657 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1894 1911 1894 1911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Weiss1">Weiss et al. 2003</xref>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 317 323 <span type="species:ncbi:10090">murine</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 853 858 <span type="species:ncbi:9606">human</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
###xml 1232 1236 <span type="species:ncbi:10090">mice</span>
###xml 1387 1391 <span type="species:ncbi:10090">mice</span>
One possible explanation for our results was that the levels of MYC induction were different in embryonic and neonatal versus adult hosts. To address this possibility, we examined total MYC protein levels by Western analysis using a polyclonal antibody that recognizes both the human c-MYC protein and the endogenous murine c-MYC (Figure 3B). In neonatal and adult mice, MYC protein levels were induced at similar levels (Figure 3B). In tumors from embryos, neonatal, and adult mice, MYC protein levels increased an additional 5- to 10-fold over the levels observed in nontransgenic and in MYC-induced nonneoplastic livers. Tumorigenic conversion of hepatocytes was associated, in all age groups of mice, with further increases in the levels of MYC protein (Figure 3B). We obtained similar results by quantitative PCR analysis of mRNA expression of the human MYC transgene (Figure 3C). In neonatal and adult mice, MYC transgene expression was induced at similar levels. In tumors from embryos, neonatal, and adult mice, the levels of MYC transgene RNA increased an additional 10-fold over the levels observed in nonmalignant hepatocytes (Figure 3C). Hence, tumorigenic conversion of hepatocytes was associated, in all age groups of mice, with further increases in the levels of MYC transgene expression. However, differences in the ability of MYC activation to initiate tumorigenesis in mice of different ages did not appear to be related to differences in the levels of induction of MYC transgene expression. The increased levels of MYC expression we observed in tumors likely reflect that the proliferating tumor cells express more abundant levels of the MYC transgene than normal hepatocytes. This observation is consistent with observations described in other transgenic models in which expression of transgenes is generally higher in tumors than it is in the normal cellular counterparts (Weiss et al. 2003).
###end p 19
###begin title 20
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation in Embryonic and Neonatal Hepatocytes Induces Cellular Proliferation and Tumorigenesis
###end title 20
###begin p 21
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 619 627 619 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figure 4</xref>
###xml 638 646 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g008">Figure 8</xref>
###xml 729 737 729 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figure 4</xref>
###xml 906 914 906 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figure 4</xref>
###xml 923 924 923 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">4</xref>
###xml 942 945 942 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 990 998 990 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">Figure 1</xref>
###xml 1007 1008 1007 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g001">4</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">Mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
To evaluate how MYC's ability to induce tumorigenesis is influenced by the age of mice, we investigated the initial consequences of MYC activation in hepatocytes during different developmental periods. Mice that overexpressed MYC during embryonic development were born with livers similar in weight and gross architecture to normal age-matched livers, yet exhibited increasing numbers of neoplastic cells from birth through the first week of life associated with progressive abdominal enlargement. At necropsy, abdominal enlargement was associated with marked hepatomegaly with a 5-fold increase in total liver weight (Figure 4A, and see Figure 8B below). Although these livers were larger, the gross architecture was preserved (Figure 4A, MYC ON versus MYC OFF). When we examined the histology of the livers in which MYC was overexpressed during embryogenesis, we found that they resembled liver cancers (Figure 4B versus 4C) similar to the MYC-induced HCCs we observed in adult mice (see Figure 1C versus 4C). Hence, MYC overexpression appears to induce cellular proliferation in neonatal hepatocytes that progresses rapidly to neoplasia.
###end p 21
###begin p 22
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 208 216 208 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figure 4</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">4</xref>
###xml 338 346 338 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figure 4</xref>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 663 671 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figure 4</xref>
To determine if MYC was inducing changes in cell cycle transit, we measured the DNA content of isolated nuclei from normal hepatocytes and hepatocytes in which MYC was activated during embryonic development (Figure 4D and 4E). Normal neonatal hepatocytes mostly contained 2N DNA content, consistent with most of the cells residing in G1 (Figure 4D). A minority of hepatocytes exhibited 4N and 2N-4N DNA content, demonstrating that few cells were in G2/M and S phase, respectively. In contrast, upon MYC activation the proportion of neonatal hepatocytes with 2N-4N DNA content substantially increased, suggesting that an increased number of cells were in S phase (Figure 4E).
###end p 22
###begin p 23
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 169 172 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 410 418 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figure 4</xref>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">4</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">4</xref>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">4</xref>
###xml 463 466 463 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
In order to confirm that MYC activation caused tumorigenesis by inducing cell proliferation, we performed Ki67 immunofluorescence and DAPI staining in tumors induced by MYC activation during embryonic development and in age-matched nontransgenic livers. Indeed, there was evidence for increased hepatocyte proliferation in the MYC-induced neonatal tumor, as demonstrated by an increase in Ki67-positive cells (Figure 4G and 4I versus 4F and 4H). We conclude that MYC activation during embryonic development causes neonatal hepatocytes to undergo DNA replication, cell cycle transit, proliferation, and almost immediate neoplastic conversion.
###end p 23
###begin p 24
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 310 318 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g002">Figure 2</xref>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 490 498 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">Figure 3</xref>
###xml 518 521 518 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 409 415 <span type="species:ncbi:10090">murine</span>
To confirm that MYC activation during embryonic development induced tumorigenesis in neonatal livers, we transplanted neoplastic hepatocytes into scid mice. We found that neoplastic neonatal hepatocytes readily formed tumors, whereas the transplantation of normal neonatal hepatocytes did not form tumors (see Figure 2D and unpublished data). Therefore, MYC overexpression during embryonic development of the murine liver causes hepatocellular tumorigenesis within the first 10 d of birth (Figure 3). We conclude that MYC overexpression results in rapid neoplastic conversion of neonatal hepatocytes.
###end p 24
###begin p 25
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 481 489 481 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">Figure 5</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 523 526 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 577 585 577 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">Figure 5</xref>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 654 662 654 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">Figure 5</xref>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">1</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
Mice in which MYC was activated at birth exhibited progressive abdominal enlargement during their second and third weeks of life, and they showed signs of tumorigenesis by 18 to 40 d of age. When these mice developed tumors their livers were ten times the normal size, were paler, exhibited a multitude of coalescing tumor nodules, and preserved a normal gross architecture (unpublished data). We did not observe any histological changes in the liver after 10 d of MYC activation (Figure 5A versus 5B); however, by 18 d of MYC activation the histology resembled liver cancers (Figure 5C versus 5D), similar to the MYC-induced HCCs we observed in adults (Figure 5D versus 1C).
###end p 25
###begin p 26
###xml 316 319 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 356 364 356 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">Figure 5</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">Figure 5</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
We performed Ki67 immunofluorescence and DAPI staining in order to determine if MYC overexpression in neonatal livers was inducing hepatocyte proliferation. At 10 d of age the liver is in an active state of proliferation; thus, there was little detectable difference in the number of Ki67-positive cells between the MYC-activated and nontransgenic livers (Figure 5E and 5I versus 5F and 5J). However, once these livers became neoplastic, there was a great increase in the number of Ki67-positive cells (Figure 5G and 5K versus 5H and 5L).
###end p 26
###begin title 27
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation in Adult Hepatocytes Induces Cellular Growth, but Not Proliferation
###end title 27
###begin p 28
###xml 178 187 178 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">Figures 4</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g005">5</xref>
###xml 363 372 363 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figures 6</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g008">8</xref>
###xml 472 475 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 595 603 595 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g008">Figure 8</xref>
###xml 656 659 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 733 741 733 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figure 6</xref>
###xml 750 751 750 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">6</xref>
###xml 757 765 757 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g008">Figure 8</xref>
###xml 921 929 921 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g007">Figure 7</xref>
###xml 952 955 952 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1033 1036 1033 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1123 1126 1123 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1151 1154 1151 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1245 1253 1245 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g008">Figure 8</xref>
###xml 820 824 <span type="species:ncbi:10090">mice</span>
We examined the initial consequences of MYC overexpression in adult hepatocytes. In contrast to the rapid neoplastic conversion we observed in embryonic or neonatal hepatocytes (Figures 4 and 5), MYC overexpression in adult hepatocytes caused a marked cellular growth, accompanied by an even greater relative nuclear growth, as observed by histological analysis (Figures 6-8). The effects of MYC overexpression on the size of adult hepatocytes depended on the duration of MYC activation. After 2 weeks of MYC overexpression, no changes were observed in cell size compared to normal hepatocytes (Figure 8C and unpublished data). However, after 4-8 weeks of MYC activation, adult hepatocytes exhibited increased cell and nuclear size (Figure 6B versus 6A and Figure 8C). Similar results were observed in over 20 different mice. Similarly, we observed that MYC induces hypertrophy of hepatocytes by flow cytometry analysis (Figure 7). Further duration of MYC activation did not induce further cell growth, as measured up to 50 weeks of MYC activation (unpublished data). Thus, there may be an absolute limit to the ability of MYC to induce liver growth. MYC activation in adult hepatocytes was not associated with a change in overall liver weight (Figure 8D). Since the cells were bigger, but the overall weight of the liver did not increase, we infer that the total number of hepatocytes was unchanged or slightly decreased. One possible explanation for these results is that MYC induced apoptosis, as described below.
###end p 28
###begin p 29
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 216 224 216 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figure 6</xref>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">6</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">6</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">6</xref>
###xml 358 366 358 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figure 6</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">6</xref>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 600 619 600 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Mateyak1">Mateyak et al. 1997</xref>
###xml 621 646 621 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Iritani1">Iritani and Eisenman 1999</xref>
###xml 648 668 648 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Johnston1">Johnston et al. 1999</xref>
###xml 670 690 670 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Grandori1">Grandori et al. 2000</xref>
###xml 692 707 692 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kim1">Kim et al. 2000</xref>
To examine if MYC activation induced proliferation of adult hepatocytes, we measured Ki67 expression by immunofluorescence. We did not observe increased Ki67 expression when MYC was overexpressed in the adult liver (Figure 6E and 6H versus 6D and 6G). Only upon neoplastic conversion of hepatocytes was there evidence for increased hepatocyte proliferation (Figure 6F and 6I). We conclude that MYC overexpression in adult hepatocytes induces increased nuclear and cell growth, but not cell proliferation. Our observations are consistent with previous reports that MYC activation induces cell growth (Mateyak et al. 1997; Iritani and Eisenman 1999; Johnston et al. 1999; Grandori et al. 2000; Kim et al. 2000).
###end p 29
###begin p 30
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 449 458 449 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figures 6</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g008">8</xref>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC activation in adult hepatocytes eventually culminated in tumorigenesis, demonstrating that some adult hepatocytes acquire the ability to undergo cell division. To confirm this, we measured the nuclear and cellular sizes in liver tumors. When we examined the cell size in ten different tumors from adult hosts, we found that in all tumors, the cell size was reduced to below normal and the nuclear size was similar to that of normal hepatocytes (Figures 6C and 8C). We were also able to confirm that the cell size of tumor cells was reduced to below normal by FACS forward versus side scatter (unpublished data). We conclude that MYC-induced malignant conversion of adult hepatocytes is associated with the acquired ability to undergo mitotic division.
###end p 30
###begin title 31
MYC Overexpression in Adult Hepatocytes Results in Endoreduplication
###end title 31
###begin p 32
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 135 138 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 464 472 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figure 6</xref>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 653 661 653 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figure 6</xref>
###xml 815 818 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1041 1058 1041 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Cerni1">Cerni et al. 1986</xref>
###xml 1060 1075 1060 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Mai1">Mai et al. 1996</xref>
###xml 1077 1097 1077 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Chernova1">Chernova et al. 1998</xref>
###xml 1099 1118 1099 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher4">Felsher et al. 2000</xref>
To further define the consequences of MYC activation on the cell cycle, we examined the DNA content of isolated nuclei from normal and MYC-activated adult hepatocytes. We expected that if adult hepatocytes were restrained from undergoing mitotic division, MYC activation might result in endoreduplication. Age-matched normal hepatocytes exhibited a 2N DNA content consistent with most of the cells residing in G1, and there was no evidence for cells in S or G2/M (Figure 6J). After MYC activation for 2 months, we found that almost all nuclei had a 4N, 8N, or 12N DNA content, suggesting that the cells replicated their DNA repeatedly without dividing (Figure 6K). Almost no cells contained the intermediate DNA content (2N-4N), demonstrating that very few cells were in S phase at any given time. We conclude that MYC activation induces endoreduplication of the genomes of normal adult hepatocytes. Our results are consistent with reports that MYC overexpression can enforce DNA replication, resulting in endoreduplication in normal cells (Cerni et al. 1986; Mai et al. 1996; Chernova et al. 1998; Felsher et al. 2000).
###end p 32
###begin p 33
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 342 350 342 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figure 6</xref>
###xml 526 534 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g006">Figure 6</xref>
###xml 545 548 545 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
We reasoned that if MYC was causing endoreduplication in adult hepatocytes by arresting cell division and enforcing DNA replication, then upon neoplastic conversion these hepatocytes must acquire the ability to undergo mitotic division and would no longer endoreduplicate. As predicted, tumors did not exhibit evidence for endoreduplication (Figure 6L). Greater than 70% of the tumor cells contained a 2N-4N DNA content and none of the cells contained greater than 4N DNA content. The majority of tumor cells were in S phase (Figure 6L). Hence, MYC-induced tumorigenesis in adult hepatocytes is associated with the acquired ability to divide mitotically.
###end p 33
###begin title 34
MYC Overexpression in Adult Hepatocytes Does Not Induce Apoptosis
###end title 34
###begin p 35
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 95 111 95 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Evan1">Evan et al. 1992</xref>
###xml 113 135 113 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris2">Pelengaris et al. 2000</xref>
###xml 137 142 137 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris4">2002b</xref>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">Figure 9</xref>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">9</xref>
###xml 394 395 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">9</xref>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">9</xref>
###xml 453 456 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 594 602 594 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">Figure 9</xref>
###xml 608 609 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">9</xref>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 761 769 761 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">Figure 9</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">9</xref>
###xml 776 777 776 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">9</xref>
###xml 784 785 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g009">9</xref>
###xml 851 854 851 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 908 931 908 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris3">Pelengaris et al. 2002a</xref>
MYC-induced apoptosis is an important mechanism that restrains MYC from causing tumorigenesis (Evan et al. 1992; Pelengaris et al. 2000, 2002b). We reasoned that MYC may induce cellular hypertrophy, but not an increase in liver mass, because MYC induces apoptosis. Normal neonatal and adult hepatocytes did not undergo apoptosis, as demonstrated by TUNEL assay or DAPI staining (Figure 9A, 9B, 9E, and 9F). Surprisingly, we could not find evidence that MYC induced apoptosis in adult hepatocytes by TUNEL assay or DAPI staining after 2, 4, or 8 weeks of MYC induction prior to tumor formation (Figure 9G and 9H and unpublished data). Contrary to what we expected, MYC activation was only associated with increased apoptosis in the hepatocytes of liver cancers (Figure 9C, 9D, 9I, and 9J). Hence, apoptosis is not necessarily the mechanism restraining MYC from causing tumorigenesis, at least in hepatocytes (Pelengaris et al. 2002a). However, we recognize that MYC could be inducing low levels of apoptosis in hepatocytes, perhaps not easily detected by TUNEL, since apoptotic cells may be rapidly eliminated from the liver through the host reticulo-endothelial system. Such a low level of apoptosis still could explain why in the adult liver hepatocytes become hypertrophic but the liver mass does not increase.
###end p 35
###begin title 36
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 74 78 <span type="species:ncbi:10090">Mice</span>
Loss of p53 Function Cooperates with MYC to Induce Tumorigenesis in Adult Mice
###end title 36
###begin p 37
###xml 154 173 154 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher4">Felsher et al. 2000</xref>
###xml 248 251 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 348 351 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 410 413 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 534 543 534 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g010">Figure 10</xref>
###xml 643 652 643 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g010">Figure 10</xref>
###xml 990 993 990 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 998 1003 998 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM2,</italic>
###xml 1022 1025 1022 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1054 1063 1054 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g010">Figure 10</xref>
###xml 1079 1082 1079 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1412 1421 1412 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g010">Figure 10</xref>
###xml 1427 1429 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g010">10</xref>
###xml 1478 1481 1478 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 1336 1340 <span type="species:ncbi:10090">mice</span>
Previously, we have shown that the loss of p53 function is required to permit the cell division of normal mouse and human fibroblasts overexpressing MYC (Felsher et al. 2000). We speculated that loss of p53 function might be similarly required for MYC activation to induce cell proliferation and tumorigenesis in hepatocytes. First, we examined if MYC activation affected p53 protein expression. We found that MYC activation was associated with an increase in p53 protein levels in adult hepatocytes, as measured by Western analysis (Figure 10A). Conversely, tumors in adult mice frequently exhibited reduced levels of p53 protein expression (Figure 10A and unpublished data). Not all tumors exhibited reduced p53 expression. Since p53 mediates its function largely through inducing the transcription of many different genes, we evaluated if tumors exhibited a loss of p53 function by measuring the expression of these target genes. We found by Northern analysis that the p53 target genes, p21 and MDM2, were induced upon MYC activation in adult livers (Figure 10C). Conversely, MYC-induced adult HCCs frequently exhibited reduced or no expression of p53 downstream targets. Notably, a tumor that exhibited high p53 protein levels, tumor 2264, exhibited a loss in expression of p53 target genes. In contrast, tumors arising in neonatal mice expressed p53 protein and exhibited the induction of p53 target genes (Figure 10B and 10C). We conclude that the adult, but not neonatal MYC-induced liver tumors require the loss of p53 function for tumorigenesis. Hence, HCCs that arise in adult versus neonatal hosts appear to occur through genetically distinct mechanisms.
###end p 37
###begin p 38
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 162 165 162 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 209 212 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 234 237 234 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 259 262 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 256 262 256 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/&#8722;</sup></italic>
###xml 316 319 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 429 432 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 549 558 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g010">Figure 10</xref>
###xml 655 664 655 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g010">Figure 10</xref>
###xml 783 801 783 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Klocke1">Klocke et al. 2001</xref>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 127 142 <span type="species:ncbi:10090">transgenic mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
To directly address if loss of any of p53's functions accelerates the ability of MYC to induce HCC in adult mice, we generated transgenic mice that overexpressed MYC in their hepatocytes in the absence of one p53 allele. We mated LAP-tTA/TRE-MYC mice with p53+/- mice that were in the FVB/N background. We activated MYC in mice when they were 6 weeks old and monitored them for morbidity. We found that even the loss of a single p53 allele was sufficient to reduce the mean latency of tumor onset in 6-week-old adult mice from 20 weeks to 15 weeks (Figure 10D). We found by PCR that tumors did not generally inactivate the second allele through deletion (Figure 10E). Our results extend previous findings that suggest that the lack of p53 function cooperates with MYC to induce HCC (Klocke et al. 2001). We conclude that even a slight reduction of p53 function greatly facilitates the ability of MYC to induce tumorigenesis in adult hepatocytes.
###end p 38
###begin title 39
Partial Hepatectomy Accelerates MYC-Induced Tumorigenesis
###end title 39
###begin p 40
###xml 443 475 443 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Michalopoulos1">Michalopoulos and DeFrances 1997</xref>
###xml 477 499 477 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kountouras1">Kountouras et al. 2001</xref>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 966 976 966 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g011">Figures 11</xref>
###xml 981 982 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g003">3</xref>
###xml 1169 1178 1169 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g011">Figure 11</xref>
###xml 1187 1188 1187 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g004">4</xref>
###xml 1237 1240 1237 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1359 1368 1359 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g011">Figure 11</xref>
###xml 1374 1376 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0020332-g011">11</xref>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
###xml 1270 1274 <span type="species:ncbi:10090">mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
###xml 1398 1402 <span type="species:ncbi:10090">mice</span>
###xml 1450 1454 <span type="species:ncbi:10090">mice</span>
Our results suggest that the ability of MYC to induce tumorigenesis in hepatocytes depends on the developmental context. We recognized that an alternative explanation is that MYC induces tumorigenesis more readily in hepatocytes that are already proliferating. Adult hepatocytes are known to undergo rapid proliferation in response to partial hepatectomy resulting in the complete regeneration of the liver within 2 weeks of surgical removal (Michalopoulos and DeFrances 1997; Kountouras et al. 2001). We found that MYC activation in adult mice that have undergone partial hepatectomy exhibited a reduced latency of tumor induction in comparison with adult mice that had not undergone surgery (mean latency of 14 weeks versus 35 weeks). However, this latency of tumorigenesis in adult mice after partial hepatectomy was still up to two magnitudes longer than what was observed when MYC was activated in embryonic and neonatal mice (<10 d and 4 weeks, respectively) (Figures 11 and 3A). In addition, tumors in mice that had undergone partial hepatectomy, unlike tumors arising in neonatal mice, were multifocal, suggesting that tumorigenesis was occurring infrequently (Figure 11A versus 4A). Similarly, upon histological analysis, after MYC was activated for 7 weeks in mice that had undergone partial hepatectomy, mice exhibited many individual foci of HCC (Figure 11B and 11C). Finally, in adult mice after partial hepatectomy, but not in neonatal mice, areas of the liver that had not undergone neoplastic conversion clearly exhibited increased cellular hypertrophy, and hence were unable to undergo mitotic division (unpublished data). We conclude that the ability of MYC to induce tumorigenesis in adult hepatocytes is accelerated after partial hepatectomy when adult hepatocytes are proliferating, but other developmentally specific parameters are more important in determining when oncogene activation will induce tumorigenesis than the ability of hepatocytes simply to proliferate.
###end p 40
###begin title 41
Discussion
###end title 41
###begin title 42
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
Developmental Context Influences MYC's Ability to Induce Cellular Proliferation
###end title 42
###begin p 43
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
Here we demonstrate that MYC's ability to induce cellular growth versus proliferation and tumorigenesis depends on the differentiative context of a cellular lineage. Our results have general implications for the mechanisms by which MYC and other oncogenes induce and are restrained from causing tumorigenesis.
###end p 43
###begin p 44
###xml 174 177 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 414 417 414 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 653 656 653 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 112 118 <span type="species:ncbi:10090">murine</span>
###xml 394 400 <span type="species:ncbi:10090">murine</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
We found that the initial consequences of MYC overexpression, as well as its ability to induce tumorigenesis in murine hepatocytes, depend on the host age. The activation of MYC during embryonic development and at birth caused gross liver enlargement and rapid emergence of neoplasia. This increased liver size resulted from increased cell number or cellular hyperplasia. In contrast, in adult murine hepatocytes, MYC activation induced cell growth, resulting in cellular hypertrophy and endoreduplication. MYC overexpression caused HCC in adult mice less frequently than in neonates, and only after a prolonged latency. We conclude that the ability of MYC to induce cellular proliferation and tumorigenesis appears to be determined by the relative developmental maturation of a cellular lineage.
###end p 44
###begin p 45
###xml 169 172 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 573 576 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1019 1022 1019 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
We recognized that an alternative explanation for our results is that only hepatocytes that are actively proliferating are susceptible to neoplastic transformation upon MYC induction. We were able to address this possibility directly by examining the consequences of MYC overexpression in adult hepatocytes after partial hepatectomy, which resulted in the immediate induction of adult hepatocyte proliferation associated with complete liver regeneration within 2 weeks. Adult mice only exhibited a modest increased susceptibility to MYC-induced tumorigenesis observed when MYC was induced in embryonic mice. This is despite the fact that after partial hepatectomy the total number of proliferating hepatocytes would be at least two magnitudes greater than in a neonatal or embryonic liver, whose total mass is much smaller. We conclude that developmentally specific parameters other than proliferation are more likely to play a causative role in the differential susceptibility of embryonic and neonatal hepatocytes to MYC-induced tumorigenesis.
###end p 45
###begin p 46
###xml 608 627 608 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Artandi1">Artandi et al. 2000</xref>
###xml 725 733 725 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-NTP1">NTP 1989</xref>
Several different development-related factors could account for our observations. The relative ability of MYC to induce tumorigenesis in developmentally immature hosts may reflect the relative increased abundance of immature hepatocytes. Homeostatic mechanisms that regulate liver size and hepatocyte proliferation may permit MYC-induced proliferative expansion in the developing livers of young hosts and restrain proliferation in the mature liver of adult hosts. Differences in rates of tumorigenesis may be related to telomerase function that monitors the distance from senescence, as recently described (Artandi et al. 2000). An unlikely possibility is that higher doses of tetracyclines may impede liver carcinogenesis (NTP 1989). The conditional model system that we have described should be useful for addressing these different possible mechanisms.
###end p 46
###begin p 47
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC,</italic>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 255 275 255 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Johnston1">Johnston et al. 1999</xref>
###xml 277 296 277 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher4">Felsher et al. 2000</xref>
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 551 554 551 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 697 700 697 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 910 933 910 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Gandarillas1">Gandarillas et al. 2000</xref>
We conclude that mechanisms that regulate mitotic division play a critical role in preventing potent oncogenes, such as MYC, from inducing cancer in adult somatic cells. MYC activation alone is capable of enforcing DNA replication, but not cell division (Johnston et al. 1999; Felsher et al. 2000). Mitotic arrest may represent a critical fail-safe mechanism. If MYC were capable of enforcing mitotic division as well as cell growth and DNA replication, then aberrant activation of MYC alone would be sufficient to induce tumorigenesis. Activation of MYC in immature hepatocytes, cells already committed to a program of cellular proliferation, is sufficient to induce tumorigenesis. Activation of MYC in adult cells must require additional genetic events that permit mitotic cell division. Notably, our interpretation of our findings is supported by similar observations previously described in keratinocytes (Gandarillas et al. 2000).
###end p 47
###begin p 48
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 215 234 215 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Mateyak1">Mateyak et al. 1997</xref>
###xml 236 261 236 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Iritani1">Iritani and Eisenman 1999</xref>
###xml 263 283 263 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Johnston1">Johnston et al. 1999</xref>
###xml 285 305 285 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Grandori1">Grandori et al. 2000</xref>
###xml 307 322 307 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kim1">Kim et al. 2000</xref>
###xml 324 342 324 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Trumpp1">Trumpp et al. 2001</xref>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 415 434 415 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Mateyak1">Mateyak et al. 1997</xref>
###xml 436 461 436 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Iritani1">Iritani and Eisenman 1999</xref>
###xml 463 483 463 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Johnston1">Johnston et al. 1999</xref>
###xml 485 505 485 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Grandori1">Grandori et al. 2000</xref>
###xml 507 522 507 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kim1">Kim et al. 2000</xref>
###xml 524 542 524 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Trumpp1">Trumpp et al. 2001</xref>
###xml 619 622 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 757 760 757 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 938 941 938 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1040 1043 1040 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
We now can offer an explanation for what previously have been described as discordant results between reports that the MYC oncogene regulates cellular proliferation and other reports that MYC regulates cell growth (Mateyak et al. 1997; Iritani and Eisenman 1999; Johnston et al. 1999; Grandori et al. 2000; Kim et al. 2000; Trumpp et al. 2001). MYC generally appears to coordinate cell growth with DNA replication (Mateyak et al. 1997; Iritani and Eisenman 1999; Johnston et al. 1999; Grandori et al. 2000; Kim et al. 2000; Trumpp et al. 2001). However, contrary to what has been described, we show that the ability of MYC to induce cell division may depend on the developmental context of the cell. In adult hepatocytes, which normally do not proliferate, MYC activation can induce cell growth and DNA replication, but not cell division. In embryonic or neonatal hepatocytes, which are intrinsically committed to cellular proliferation, MYC activation induces cell growth, DNA replication, and mitotic division. Hence, the consequences of MYC activation appear to depend on the previous commitment of cells in a specific developmental state to a cellular program capable only of growth versus growth and cellular proliferation. It is not clear whether the hepatocytes that ultimately give rise to the tumors we observed derive from mitotically arrested diploid hepatocytes or from polyploid hepatocytes that acquire the capacity to undergo mitotic division.
###end p 48
###begin title 49
MYC Is Restrained from Inducing Proliferation by an Arrest in Cell Division
###end title 49
###begin p 50
###xml 131 141 131 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Sherr1">Sherr 1998</xref>
###xml 143 165 143 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Vogelstein1">Vogelstein et al. 2000</xref>
###xml 167 185 167 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Wahl1">Wahl and Carr 2001</xref>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 236 256 236 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Chernova1">Chernova et al. 1998</xref>
###xml 258 275 258 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Zindy1">Zindy et al. 1998</xref>
###xml 277 296 277 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Schmitt1">Schmitt et al. 1999</xref>
###xml 298 317 298 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher4">Felsher et al. 2000</xref>
###xml 319 339 319 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Grandori1">Grandori et al. 2000</xref>
###xml 341 358 341 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Oster1">Oster et al. 2002</xref>
###xml 360 383 360 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris3">Pelengaris et al. 2002a</xref>
###xml 385 390 385 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris4">2002b</xref>
###xml 442 458 442 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Evan1">Evan et al. 1992</xref>
###xml 460 477 460 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Zindy1">Zindy et al. 1998</xref>
###xml 479 498 479 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Schmitt1">Schmitt et al. 1999</xref>
###xml 500 520 500 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Grandori1">Grandori et al. 2000</xref>
###xml 522 539 522 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Oster1">Oster et al. 2002</xref>
###xml 541 564 541 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris3">Pelengaris et al. 2002a</xref>
###xml 566 571 566 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris4">2002b</xref>
###xml 618 621 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 874 892 874 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Wahl1">Wahl and Carr 2001</xref>
Many reports document that p53 functions as a general surveillance checkpoint that prevents oncogenes from inducing tumorigenesis (Sherr 1998; Vogelstein et al. 2000; Wahl and Carr 2001). MYC activation is known to induce p53 function (Chernova et al. 1998; Zindy et al. 1998; Schmitt et al. 1999; Felsher et al. 2000; Grandori et al. 2000; Oster et al. 2002; Pelengaris et al. 2002a, 2002b), which in turn has been shown to cause apoptosis (Evan et al. 1992; Zindy et al. 1998; Schmitt et al. 1999; Grandori et al. 2000; Oster et al. 2002; Pelengaris et al. 2002a, 2002b). In contrast to these reports, we found that MYC is restrained from causing cell division in adult hepatocytes, at least in part, through a p53-dependent mechanism. Our results are consistent with many reports that demonstrate that p53 regulates checkpoints during DNA replication and during mitosis (Wahl and Carr 2001).
###end p 50
###begin p 51
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 268 289 268 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-McCormack1">McCormack et al. 1998</xref>
###xml 291 308 291 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Blyth1">Blyth et al. 2000</xref>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 576 579 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 618 621 618 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 697 713 697 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Jain1">Jain et al. 2002</xref>
###xml 906 918 906 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher1">Felsher 2003</xref>
We conclude that apoptosis is not the mechanism that precludes MYC from inducing neoplasia in hepatocytes. Rather, apoptosis is associated with MYC-induced neoplastic progression. Notably, similar results have been described in MYC-induced breast cancer and lymphoma (McCormack et al. 1998; Blyth et al. 2000). There are several possible explanations for this discordance between our results and many previous reports. MYC may only induce apoptosis in some cellular lineages or only in particular differentiative contexts. In this regard, we have shown that upon inactivating MYC, tumor cells differentiated, and upon MYC reactivation in this new differentiative state, cells underwent apoptosis (Jain et al. 2002). Thus, whether oncogene activation induces proliferation, growth, arrest, or apoptosis may depend on the gene expression program of a cell associated with a particular differentiative state (Felsher 2003).
###end p 51
###begin p 52
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 288 291 288 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 411 414 411 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 719 738 719 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher4">Felsher et al. 2000</xref>
###xml 548 553 <span type="species:ncbi:10090">mouse</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
We found that the ability of MYC overexpression to induce tumorigenesis in adult hepatocytes often requires the loss of p53 function. MYC-induced HCC exhibited reduced p53 protein expression and transcriptional activity. The introduction of a single mutant p53 allele greatly accelerated MYC's ability to induce tumorigenesis. Hence, in adult hepatocytes, loss of p53 function appears to be necessary to permit MYC activation to induce cellular proliferation and tumorigenesis. Our results here are similar to our previous observations that normal mouse and human fibroblasts overexpressing MYC replicate and even endoreduplicate their DNA, but are unable to undergo mitotic division unless p53 function has been lost (Felsher et al. 2000).
###end p 52
###begin title 53
Specific Developmental Contexts Permit Oncogene-Induced Tumorigenesis
###end title 53
###begin p 54
###xml 576 593 576 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Adams1">Adams et al. 1985</xref>
###xml 595 618 595 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Spanopoulou1">Spanopoulou et al. 1989</xref>
###xml 620 642 620 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris1">Pelengaris et al. 1999</xref>
###xml 644 661 644 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Blyth1">Blyth et al. 2000</xref>
###xml 108 116 <span type="species:ncbi:9606">children</span>
We may be able to explain why the frequency and spectrum of neoplasia vary with the host's age. In general, children are susceptible to tumors of the hematopoietic system, musculo-skeletal system, and central nervous system, whereas adults are susceptible more frequently to tumors derived from epithelial lineages, such as colon, lung, breast, prostate, and liver. The ability of oncogenes to induce cancer may be dependent upon the differentiative context. Frequently, oncogene activation has been associated with the malignant conversion of immature cellular compartments (Adams et al. 1985; Spanopoulou et al. 1989; Pelengaris et al. 1999; Blyth et al. 2000).
###end p 54
###begin p 55
###xml 189 206 189 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Chang1">Chang et al. 1991</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Chang2">1997</xref>
###xml 541 553 541 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Greaves1">Greaves 1986</xref>
###xml 555 575 555 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Klein1">Klein and Klein 1986</xref>
###xml 879 898 879 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Serrano1">Serrano et al. 1997</xref>
###xml 900 915 900 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Lin1">Lin et al. 1998</xref>
###xml 917 932 917 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Zhu1">Zhu et al. 1998</xref>
###xml 934 951 934 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Dimri1">Dimri et al. 2000</xref>
###xml 992 1014 992 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Pelengaris2">Pelengaris et al. 2000</xref>
###xml 1127 1131 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC,</italic>
###xml 52 58 <span type="species:ncbi:9606">humans</span>
We may be able to explain why neonatal versus adult humans that have become infected with hepatitis B succumb to HCC with a 100-fold-increased frequency and reduced latency of tumor onset (Chang et al. 1991, 1997). We infer that oncogenes in general are more potent in inducing cancer in hepatocytes of younger hosts because these cells are committed to a developmental program permissive to tumorigenesis. Cancers frequently correspond to the malignant expansion of specific immature differentiative states within a given cellular lineage (Greaves 1986; Klein and Klein 1986). It would be advantageous for adult somatic cells, which are required to be long lived, to acquire mechanisms that prevent single oncogenes from inducing inappropriate cellular proliferation and thereby tumorigenesis. Two such mechanisms have been proposed: Some oncogenes induce premature senescence (Serrano et al. 1997; Lin et al. 1998; Zhu et al. 1998; Dimri et al. 2000), and other oncogenes induce apoptosis (Pelengaris et al. 2000). Here we have provided evidence for a different mechanism: The aberrant activation of proto-oncogenes, such as MYC, in the developmental context of adult somatic cells appears to be inherently prohibited from inducing mitotic division.
###end p 55
###begin p 56
The intrinsic inhibition of a proliferative program in mature somatic cells may be a more parsimonious mechanism than apoptosis as a means of restraining tumorigenesis because it would permit otherwise normal fully differentiated somatic cells to continue to operate despite their acquisition of an activating mutation in an oncogene. In some cases, it would be advantageous to arrest cells rather than induce their apoptosis. Immature cells, which are committed to a program of proliferative expansion, are inherently more susceptible to oncogene-induced autonomous proliferation and tumorigenesis. In immature cells, apoptosis may be the only mechanism that could prevent tumorigenesis. Thus, the differentiative state and epigenetic program of a cell influences whether an oncogene induces cellular senescence, mitotic arrest, or apoptosis.
###end p 56
###begin p 57
###xml 152 168 152 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Jain1">Jain et al. 2002</xref>
###xml 170 182 170 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher1">Felsher 2003</xref>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC,</italic>
###xml 494 497 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 748 751 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
Generally, oncogenes may cause tumorigenesis most readily in developmental contexts that provide a gene expression program permissive to tumorigenesis (Jain et al. 2002; Felsher 2003). Pathologic conditions that trigger the expansion of immature cells-tissue injury and regeneration, infection, and autoimmune processes-may be associated with cancer because they change the cellular state, now permitting a single oncogene, such as MYC, to initiate tumorigenesis. In this regard, we found that MYC accelerated tumorigenesis in adult hosts that had undergone partial hepatectomy and were undergoing liver regeneration-a state that induces robust cellular proliferation. However, tumorigenesis was not accelerated to the same degree as observed when MYC was activated in embryonic or neonatal hosts. Therefore, inducing the capacity of a cell to proliferate alone is unlikely to be sufficient to confer susceptibility to tumorigenesis. It has long been appreciated that conferring the ability of a cell to proliferate is not sufficient to induce tumorigenesis. Other developmentally specific parameters may play a more critical role in defining when oncogene activation results in tumorigenesis. The model system we have developed should prove useful in defining how particular developmental contexts and pathologic states contribute to tumorigenesis.
###end p 57
###begin title 58
Materials and Methods
###end title 58
###begin title 59

###end title 59
###begin title 60
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice
###end title 60
###begin p 61
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 86 110 86 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Felsher3">Felsher and Bishop 1999b</xref>
###xml 174 193 174 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Kistner1">Kistner et al. 1996</xref>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 421 424 420 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">Mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
The TRE-MYC transgenic line generated for these experiments was described previously (Felsher and Bishop 1999b). The LT-tTA transgenic line was kindly provided by H. Bujard (Kistner et al. 1996). The p53+/- mice were generously provided by A. Bradley. Mice were mated and screened by PCR. MYC expression was activated by removing doxycycline treatment (100 mug/ml) from the drinking water of mice transgenic for both TRE-MYC and LAP-tTA.
###end p 61
###begin title 62
Tumorigenicity assays
###end title 62
###begin p 63
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 1111 1112 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1152 1156 1138 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 1431 1432 1416 1417 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1434 1435 1419 1420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1502 1503 1487 1488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 317 321 <span type="species:ncbi:10090">Mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1228 1232 <span type="species:ncbi:10090">Mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">Mice</span>
MYC was activated in the liver by removing doxycycline treatment from the water. MYC was activated during embryonic development by removing doxycycline treatment from the mating cage before conception. MYC was activated at birth by removing doxycycline from the mating cage immediately after the birth of the litter. Mice were monitored daily and were sacrificed when moribund. During necropsy, liver tissues were saved by fixation in 10% buffered formalin or by being snap frozen in liquid nitrogen. For transplantation, liver tumor specimens were sliced into small pieces, incubated first in calcium-free Hank's Buffered Saline Solution (HBSS) on a stirring plate at 37 degreesC for 20 min, then washed and resuspended in 1x digestion buffer with 1.5 mg/ml collagenase, and incubated on a stirring plate at 37 degreesC for an additional 40 min. The solution was then filtered through a 100-mum filter, washed, and resuspended in PBS twice. After the first wash, the solution was resuspended in 10 ml of PBS. After the second filtering and wash, the solution was resuspended in 500 mul of PBS. A quantity of 106 cells was injected subcutaneously into scid mice (250 mul per injection) using a 1-ml syringe and 27-gauge needle. Mice showed signs of tumorigenesis within 2-3 weeks of inoculation. Mice were sacrificed when tumors reached 2 cm in size. To prepare 5x digestion buffer, 1.12 g of KCl, 37.94 g of NaCl, 0.69 g of NaH2PO4*H2O, and 9.9 g of dextrose monohydrate were dissolved in 1 liter of H2O.
###end p 63
###begin title 64
Partial hepatectomy
###end title 64
###begin p 65
###xml 226 230 <span type="species:ncbi:10090">Mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
The median and left lateral lobes comprise about 70% of the liver and their removal is recognized classically as a partial hepatectomy. We performed a one-third partial hepatectomy, removing only the median lobe of the liver. Mice were anesthetized with 16 mg/kg ketamine/xylazine. An incision was made through the midline ventral abdominal skin and abdominal muscles, extending from just above the xiphoid cartilage to about halfway towards the base of the tail. A small bolster was placed under the thorax, causing the liver to fall forwards away from the diaphragm. The liver was pushed out and the suspensory ligaments were cut with blunt-end scissors. The median lobe was raised and a ligature was tied around it with the blood vessels at the base. The liver lobe was removed by cutting close to the ligature with sharp scissors. The bolster was removed and the muscle and skin incisions were closed. The mice were monitored hourly for pain and dehydration after the procedure.
###end p 65
###begin title 66
Histology
###end title 66
###begin p 67
###xml 449 454 <span type="species:ncbi:10090">mouse</span>
###xml 460 465 <span type="species:ncbi:9606">human</span>
###xml 1238 1243 <span type="species:ncbi:10090">mouse</span>
###xml 1249 1254 <span type="species:ncbi:9606">human</span>
###xml 1429 1434 <span type="species:ncbi:10090">mouse</span>
Liver tissues were fixed in 10% buffered formalin for 24 h and then transferred to 70% ethanol until embedding in paraffin. Tissue sections 4 mum thick were cut from paraffin-embedded blocks and placed on glass slides. Hematoxylin and eosin (H&E) staining was performed using standard procedures. The Stanford Histology Core laboratory prepared paraffin sections and performed H&E staining. We measured Ki67 expression by immunofluorescence using a mouse anti-human Ki67 monoclonal antibody (BD Biosciences, Palo Alto, California, United States). We used the Vector M.O.M. Basic Kit (Vector Laboratories, Burlingame, California, United States). Sections were deparaffinized with xylene and rehydrated through graded alcohol washes, followed by antigen retrieval in a microwave for 15 min in Vector Antigen Unmasking solution (H-3300). The slides were then incubated in 100 mM glycine for 2 x 8 min to reduce fluorescent background. Slides were blocked by incubation in avidin for 10 min followed by biotin for 10 min using the Dako biotin blocking system (DAKO Corporation, Carpinteria, California, United States) and subsequently incubated for 1 h in M.O.M. IgG-blocking reagent diluted 1:4 in PBS. Slides were then incubated for 1 h in mouse anti-human Ki67 monoclonal antibody diluted 1:100 in M.O.M. diluent. Slides were washed in TBST for 3 x 5 min to reduce background and were then treated with M.O.M. biotin-labeled anti-mouse IgG, diluted 1:250 in M.O.M. diluent. Following another 3 x 5 min of TBST washes, slides were incubated for exactly 45 min in Cy3-conjugated streptavidin diluted 1:800 in PBS (Amersham Biosciences, Piscataway, New Jersey, United States) in the dark. To visualize nuclei, slides were counterstained with 0.2 mug/ml DAPI. Ki67-positive cells were visualized by fluorescence microscopy.
###end p 67
###begin title 68
Western blot analysis
###end title 68
###begin p 69
###xml 600 606 <span type="species:ncbi:9986">rabbit</span>
###xml 643 648 <span type="species:ncbi:10090">mouse</span>
###xml 653 658 <span type="species:ncbi:9606">human</span>
###xml 789 795 <span type="species:ncbi:9986">rabbit</span>
Western analysis was performed using conventional techniques. Liver tissues were disrupted and protein was isolated using a pestle and tube homogenizer in NP-40 lysis buffer. Equal protein was loaded in each lane, as quantitated by the Bicinchoninic Acid (BCA) Protein Assay (Pierce, Rockford, Illinois, United States). Proteins were electrophoresed on 10% Tris-HCl polyacrylamide gels at 100 V for 60 min and transferred on PVDF membranes at 100 V for 60 min. The membrane was blocked in 5% nonfat dry milk solution in TBS at 4 degreesC overnight. MYC protein expression was detected using the C-19 rabbit polyclonal antibody that recognizes mouse and human MYC (Santa Cruz Biotechnology, Santa Cruz, California, United States). p53 protein expression was detected using the NCL-p53-CM5p rabbit polyclonal antibody (Vector Laboratories). As a positive control, we used a hematopoietic tumor previously shown to overexpress p53 that was generously provided by Dr. Kevin Smith.
###end p 69
###begin title 70
Cell and nucleus size measurements
###end title 70
###begin p 71
Images of H&E-stained liver sections were made with a Nikon Eclipse E800 microscope utilizing a Spot RT Slider digital camera (Diagnostic Instruments, Sterling Heights, Michigan, United States) and Spot Advanced Software (version 3.2.4, Diagnostic Instruments). To estimate cellular and nuclear volume, the radii of at least five hepatocytes per field were measured in at least three fields.
###end p 71
###begin title 72
Hepatocyte isolation
###end title 72
###begin p 73
###xml 70 81 70 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Seglen1">Seglen 1976</xref>
###xml 83 105 83 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Bumgardner1">Bumgardner et al. 1990</xref>
Hepatocytes were collected by a two-step in situ perfusion technique (Seglen 1976; Bumgardner et al. 1990). First, the inferior vena cava was cannulated and the liver perfused with calcium-free EGTA buffer followed by calcium-containing collagenase buffer (Invitrogen, Carlsbad, California, United States). After the perfusion, the liver was excised and mechanically disrupted in Williams' E medium (Sigma-Aldrich, St. Louis, Missouri, United States). The resulting slurry was filtered through a 40-mum filter, and viable hepatocytes were isolated by Percoll gradient centrifugation. The pelleted hepatocytes were washed serially with Williams' E medium and counted prior to further analyses.
###end p 73
###begin title 74
Cell size measurements by FACS analysis
###end title 74
###begin p 75
Cell size was determined by FACS forward versus light scatter of isolated hepatocytes utilizing a Becton Dickinson FACSCaliber (BD Biosciences). Data were analyzed using Cellquest v3.3 Software (BD Biosciences).
###end p 75
###begin title 76
DNA content
###end title 76
###begin p 77
###xml 262 281 262 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Oppedal1">Oppedal et al. 1988</xref>
Nuclei were prepared for staining by touching a cut piece of liver to superfrost slides. The smears were then air dried, fixed in formalin for 5 min, and stored in 70% ethanol. The nuclei were stained for DNA content analysis according to the Feulgen technique (Oppedal et al. 1988).
###end p 77
###begin title 78
Apoptosis assay
###end title 78
###begin p 79
Apoptosis was detected using terminal deoxyribonucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining, using the In Situ Death Detection Kit (Boehringer Mannheim, Indianapolis, Indiana, United States). In order to visualize the nuclei, cells were counterstained with DAPI (0.2 mug/ml). TUNEL-positive cells were visualized by fluorescence microscopy.
###end p 79
###begin title 80
Northern blot analysis
###end title 80
###begin p 81
###xml 516 526 516 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21, MDM2,</italic>
###xml 571 578 571 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(GAPDH)</italic>
###xml 600 619 600 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Macleod1">Macleod et al. 1995</xref>
###xml 621 634 621 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-el-Deiry1">el-Deiry 1998</xref>
Northern blotting and probing were performed using standard methods. RNA samples were isolated according to the Trizol product manual specifications using a Kontes 1-ml glass tissue homogenizer. A formaldehyde, 1% agarose gel was used to run the Northerns, and transferring was done overnight in 20x SSC. Blots were washed in 2x SSC, cross-linked twice in a Stratalinker UV source, and pre-hybed and hybridized using the UltraHyb (Ambion, Austin, Texas, United States) product specifications. cDNAs corresponding to p21, MDM2, and glyceraldehye-3-phosphate dehydrogenase (GAPDH) were used as probes (Macleod et al. 1995; el-Deiry 1998). The probes were generated through random priming reactions. Kodak BioMax MS film was used to expose the blots.
###end p 81
###begin title 82
Loss of p53 heterozygosity analysis by PCR
###end title 82
###begin p 83
###xml 152 175 152 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="plbi-02-11-03-Timme1">Timme and Thompson 1994</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
To evaluate loss of heterozygosity of liver tumors derived from mice heterozygous for p53 deletion, PCR analysis was performed as previously described (Timme and Thompson 1994).
###end p 83
###begin title 84
RNA isolation and quantification
###end title 84
###begin p 85
###xml 261 264 261 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
Total cellular RNA was isolated from snap-frozen liver tissue using the Invitrogen Micro-to-Midi Total RNA Purification System according to the manufacturer's instructions. The amount of total RNA isolated from tissues was quantified using spectrophotometric OD260 measurements. The quality of RNA was measured on a formaldehyde, 1% agarose gel.
###end p 85
###begin title 86
Real-time PCR
###end title 86
###begin p 87
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-MYC</italic>
###xml 370 373 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 529 535 529 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH.</italic>
###xml 1087 1090 1073 1076 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
###xml 1436 1437 1398 1399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1434 1439 1396 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C<sub>t</sub>),</italic>
###xml 1825 1830 1787 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-MYC</italic>
###xml 1885 1891 1847 1853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH.</italic>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 523 528 <span type="species:ncbi:10090">mouse</span>
###xml 1639 1644 <span type="species:ncbi:9606">Human</span>
###xml 1742 1747 <span type="species:ncbi:10090">Mouse</span>
###xml 1786 1791 <span type="species:ncbi:9606">Human</span>
###xml 1819 1824 <span type="species:ncbi:9606">human</span>
###xml 1845 1850 <span type="species:ncbi:10090">Mouse</span>
The RNA of human c-MYC and rodent GAPDH were measured by real-time quantitative RT-PCR using the 5' nuclease technology on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster City, California, United States). The probe sequences for human c-MYC were forward primer 5'-CCCCTGGTGCTCCATGAG-3' and reverse primer 5'-GCCTGCCTCTTTCCACAGA-3'. The human c-MYC probe, 5'-TCCTCCTCAGAGTCGC-3', was labeled with FAM dye-MGB. A VIC TaqMan rodent GAPDH control reagents kit (Applied Biosystems) was used to measure mouse GAPDH. The RNA was reverse transcribed using the High-Capacity cDNA Archive Kit (Applied Biosystems) according to the manufacturer's protocol with a minor modification, the addition of RNase inhibitor (Applied Biosystems) at a final concentration of 1 U/mul. Samples were incubated at 25 degreesC for 10 min and 37 degreesC for 180 min. PCR reactions were prepared in a final volume of 20 mul, with final concentrations of 1x TaqMan Universal PCR Master Mix (Applied Biosystems) and cDNA derived from 20 ng of input RNA as determined by spectrophotometric OD260 measurements. Thermal cycling conditions comprised an initial UNG incubation at 50 degreesC for 2 min, AmpliTaqGold DNA polymerase activation at 95 degreesC for 10 min, 40 cycles of denaturation at 95 degreesC for 15 s, and annealing and extension at 60 degreesC for 1 min. Each measurement was performed in triplicate and the threshold cycle (Ct), the fractional cycle number at which the amount of amplified target reached a fixed threshold, was determined. For calibration and generation of standard curves, we used cDNA prepared from Universal Human Reference RNA (Stratagene, La Jolla, California, United States) and cDNA prepared from Universal Mouse Reference RNA (Stratagene). Universal Human Reference RNA was used for human c-MYC and Universal Mouse Reference RNA was used for rodent GAPDH.
###end p 87
###begin title 88
Supporting Information
###end title 88
###begin title 89
Accession Numbers
###end title 89
###begin p 90
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 160 165 <span type="species:ncbi:10090">mouse</span>
###xml 186 191 <span type="species:ncbi:10090">mouse</span>
Swiss-Prot accession numbers () for the loci discussed in this paper are the following: Cdkn1a (mouse), P39689; Mdm2 (mouse), P23804; Myc (human), P01106; Myc (mouse), P01108; and Tp53 (mouse), P02340.
###end p 90
###begin p 91
###xml 742 745 742 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
We thank the members of the Felsher laboratory for their helpful suggestions, and Dr. Michael Cleary and Dr. Paul Khavari for a critical reading of the manuscript. We thank Debbie Czerwinski for her guidance with the real-time PCR and the Levy and Chu laboratories for providing us with primers and probes. We thank Dr. Jackie Maher for assistance in performing partial hepatectomies. We thank Dr. Kevin Smith and Flora Tang for providing us with help performing the Western analysis for p53 expression. We thank Dr. Alexander Borowsky and Dr. Richard Sibley for assistance in examining histology. We thank Dr. Herman Bujard for generously providing us with the LAP-tTA mice. We thank Dr. Alan Bradley for generously providing us with the p53+/- mice. We thank Dr. Alice Fan and Kim Komatsubara for helping editing the text. This work was supported by the National Cancer Institute (grant numbers K08-CA75967-01, R01-CA85610), an American Society of Clinical Oncology Young Investigator Award, a Pilot Feasibility Grant from the University of California, San Francisco Liver Center, a Pilot Grant from the Stanford Digestive Disease Consortium, the Emerald Foundation (DWF), the National Cancer Institute (Grant Number 5T32 CA09302-27) (SB), the Swedish Cancer Society, and the Cancerforeningen in Stockholm (AZ).
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis
###end article-title 93
###begin article-title 94
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
###end article-title 94
###begin article-title 95
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
###end article-title 95
###begin article-title 96
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice
###end article-title 96
###begin article-title 97
Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype
###end article-title 97
###begin article-title 98
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
###end article-title 98
###begin article-title 99
Comparison of in vivo and in vitro immune response to purified hepatocytes
###end article-title 99
###begin article-title 100
###xml 120 123 <span type="species:ncbi:10116">rat</span>
c-myc and functionally related oncogenes induce both high rates of sister chromatid exchange and abnormal karyotypes in rat fibroblasts
###end article-title 100
###begin article-title 101
###xml 0 17 <span type="species:ncbi:10407">Hepatitis B virus</span>
###xml 33 50 <span type="species:ncbi:10407">hepatitis B virus</span>
Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood
###end article-title 101
###begin article-title 102
###xml 93 101 <span type="species:ncbi:9606">children</span>
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group
###end article-title 102
###begin article-title 103
MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification
###end article-title 103
###begin article-title 104
c-Myc target genes involved in cell growth, apoptosis, and metabolism
###end article-title 104
###begin article-title 105
###xml 149 152 <span type="species:ncbi:10116">rat</span>
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain
###end article-title 105
###begin article-title 106
Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor
###end article-title 106
###begin article-title 107
Regulation of p53 downstream genes
###end article-title 107
###begin article-title 108
Induction of apoptosis in fibroblasts by c-myc protein
###end article-title 108
###begin article-title 109
Cancer revoked: Oncogenes as therapeutic targets
###end article-title 109
###begin article-title 110
Transient excess of MYC activity can elicit genomic instability and tumorigenesis
###end article-title 110
###begin article-title 111
Reversible tumorigenesis by MYC in hematopoietic lineages
###end article-title 111
###begin article-title 112
Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts
###end article-title 112
###begin article-title 113
###xml 64 73 <span type="species:ncbi:9995">woodchuck</span>
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours
###end article-title 113
###begin article-title 114
###xml 26 31 <span type="species:ncbi:9606">human</span>
Normal and c-Myc-promoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication
###end article-title 114
###begin article-title 115
The Myc/Max/Mad network and the transcriptional control of cell behavior
###end article-title 115
###begin article-title 116
Differentiation-linked leukemogenesis in lymphocytes
###end article-title 116
###begin article-title 117
c-Myc enhances protein synthesis and cell size during B lymphocyte development
###end article-title 117
###begin article-title 118
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
###end article-title 118
###begin article-title 119
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila myc regulates cellular growth during development
###end article-title 119
###begin article-title 120
Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations
###end article-title 120
###begin article-title 121
Amplification of c-myc in hepatocellular carcinoma: Correlation with clinicopathologic features, proliferative activity and p53 overexpression
###end article-title 121
###begin article-title 122
Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo
###end article-title 122
###begin article-title 123
###xml 84 99 <span type="species:ncbi:10090">transgenic mice</span>
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
###end article-title 123
###begin article-title 124
Conditioned tumorigenicity of activated oncogenes
###end article-title 124
###begin article-title 125
###xml 48 63 <span type="species:ncbi:10090">transgenic mice</span>
Lack of p53 accelerates hepatocarcinogenesis in transgenic mice constitutively overexpressing c-myc in the liver
###end article-title 125
###begin article-title 126
Liver regeneration after hepatectomy
###end article-title 126
###begin article-title 127
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
###end article-title 127
###begin article-title 128
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
###end article-title 128
###begin article-title 129
###xml 68 71 <span type="species:ncbi:10116">rat</span>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines
###end article-title 129
###begin article-title 130
###xml 30 33 <span type="species:ncbi:10116">rat</span>
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination
###end article-title 130
###begin article-title 131
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability
###end article-title 131
###begin article-title 132
Liver regeneration
###end article-title 132
###begin article-title 133
###xml 7 22 <span type="species:ncbi:10090">transgenic mice</span>
Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer
###end article-title 133
###begin article-title 134
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis
###end article-title 134
###begin article-title 135
###xml 100 104 <span type="species:ncbi:10116">rats</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
NTP toxicology and carcinogenesis studies of tetracycline hydrochloride (CAS no. 64-75-5) in F344/N rats and B6C3F1 mice (feed studies)
###end article-title 135
###begin article-title 136
Feulgen DNA values in Wilms' tumour in relation to prognosis
###end article-title 136
###begin article-title 137
The myc oncogene: MarvelouslY complex
###end article-title 137
###begin article-title 138
Reversible activation of c-myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
###end article-title 138
###begin article-title 139
Action of Myc in vivo-proliferation and apoptosis
###end article-title 139
###begin article-title 140
c-Myc: More than just a matter of life and death
###end article-title 140
###begin article-title 141
Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression
###end article-title 141
###begin article-title 142
Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma
###end article-title 142
###begin article-title 143
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: Oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles
###end article-title 143
###begin article-title 144
###xml 36 51 <span type="species:ncbi:10090">transgenic mice</span>
Oncogene-induced liver neoplasia in transgenic mice
###end article-title 144
###begin article-title 145
###xml 113 128 <span type="species:ncbi:10090">transgenic mice</span>
Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption
###end article-title 145
###begin article-title 146
###xml 109 124 <span type="species:ncbi:10090">transgenic mice</span>
Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-Myc and transforming growth factor alpha transgenes
###end article-title 146
###begin article-title 147
###xml 67 82 <span type="species:ncbi:10090">transgenic mice</span>
Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-myc and transforming growth factor-alpha in the liver
###end article-title 147
###begin article-title 148
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
###end article-title 148
###begin article-title 149
###xml 24 27 <span type="species:ncbi:10116">rat</span>
Preparation of isolated rat liver cells
###end article-title 149
###begin article-title 150
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
###end article-title 150
###begin article-title 151
Tumor surveillance via the ARF-p53 pathway
###end article-title 151
###begin article-title 152
###xml 59 74 <span type="species:ncbi:10090">transgenic mice</span>
Complex lymphoid and epithelial thymic tumours in Thy1-myc transgenic mice
###end article-title 152
###begin article-title 153
###xml 26 31 <span type="species:ncbi:9606">human</span>
Molecular pathogenesis of human hepatocellular carcinoma
###end article-title 153
###begin article-title 154
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Rapid allelotype analysis of p53 knockout mice
###end article-title 154
###begin article-title 155
c-Myc regulates mammalian body size by controlling cell number but not cell size
###end article-title 155
###begin article-title 156
###xml 60 65 <span type="species:ncbi:9606">human</span>
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma
###end article-title 156
###begin article-title 157
Surfing the p53 network
###end article-title 157
###begin article-title 158
###xml 75 80 <span type="species:ncbi:4932">yeast</span>
The evolution of diverse biological responses to DNA damage: Insights from yeast and p53
###end article-title 158
###begin article-title 159
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Genetic determinants of malignancy in a mouse model for oligodendroglioma
###end article-title 159
###begin article-title 160
###xml 14 19 <span type="species:ncbi:9606">human</span>
Senescence of human fibroblasts induced by oncogenic Raf
###end article-title 160
###begin article-title 161
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
###end article-title 161
###begin title 162
Abbreviations
###end title 162
###begin p 163
hepatocellular carcinoma
###end p 163
###begin p 164
tetracycline regulatory system
###end p 164
###begin title 165
Figures and Tables
###end title 165
###begin title 166
MYC Overexpression in Adult Hepatocytes Results in HCC
###end title 166
###begin p 167
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
(A) Western blot analysis demonstrating that mice transgenic for both LAP-tTA and TRE-MYC conditionally express MYC protein in their hepatocytes in the absence (-) but not in the presence (+) of doxycycline.
###end p 167
###begin p 168
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
(B) Adult mouse with MYC-induced liver tumor.
###end p 168
###begin p 169
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(C) Histology of an adult MYC-induced liver tumor.
###end p 169
###begin p 170
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
(D) Gross pathology of an adult liver tumor transplanted subcutaneously into a scid mouse.
###end p 170
###begin p 171
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
(E) Histology of an adult tumor transplanted subcutaneously into a scid mouse.
###end p 171
###begin title 172
MYC-Induced Hepatic Tumors Are Invasive and Metastatic
###end title 172
###begin p 173
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
(A) Adult mouse with MYC-induced liver tumor that has metastasized to the abdomen and the lungs.
###end p 173
###begin p 174
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(B) Histology of an adult MYC-induced lung metastasis.
###end p 174
###begin p 175
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(C) Histology of an adult MYC-induced liver tumor.
###end p 175
###begin p 176
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">scid</italic>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
(D) Gross pathology of a liver tumor from a neonatal host transplanted subcutaneously into a scid mouse.
###end p 176
###begin title 177
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC's Ability to Induce HCC Is Inversely Correlated with the Age of the Host at the Time of MYC Activation
###end title 177
###begin p 178
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 264 267 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 329 332 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 390 393 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 560 563 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 700 703 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 16 31 <span type="species:ncbi:10090">transgenic mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 444 459 <span type="species:ncbi:10090">transgenic mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">Mice</span>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
(A) Survival of transgenic mice demonstrates that tumorigenesis in the liver is inversely correlated with the age of the host at the time of MYC induction. Shown are cases where MYC was constitutively expressed (blacksquare, square, filled), newborn mice in which MYC was activated at birth (black triangle), young mice in which MYC was activated at 4 weeks of age (*), adult mice in which MYC was activated at 6-12 weeks of age (diamond), and transgenic mice treated with doxycycline (square). Cohorts consisted of 15-30 mice. Mice were scored when moribund. MYC transgene expression was induced to similar levels in the differently aged cohorts of mice. Survival time is measured as the time after MYC induction.
###end p 178
###begin p 179
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 78 84 <span type="species:ncbi:10090">murine</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
(B) Western blot examining total MYC protein levels (human MYC and endogenous murine c-MYC) in mice when MYC is induced during embryonic development, activated at birth, and activated during adulthood (after 10 weeks of age). Adult mice exhibited a progressive increase in MYC protein levels during the course of MYC induction, with a significant increase in MYC protein in tumors. MYC protein levels in neonatal mice in which MYC was activated at birth were slightly increased at 10 d of age, and significantly increased at 18 d of age when these mice developed liver tumors. Liver tumors in 2- and 6-d-old neonatal mice that overexpressed MYC during embryonic development exhibited MYC protein levels similar to those observed in neonatal and adult tumors.
###end p 179
###begin p 180
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 181 184 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 372 375 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 532 535 532 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">Mice</span>
(C) Real-time PCR analysis showing human MYC RNA levels in mice after different durations of MYC transgene induction. Adult livers exhibited a small increase in MYC RNA levels upon MYC activation, and a much greater increase in MYC RNA in MYC-induced tumors (black bars). In neonatal mice in which the MYC transgene was induced at birth, MYC RNA levels rose after 10 d of MYC activation. When these neonatal mice developed liver tumors, they exhibited MYC RNA levels similar to those seen in adult tumors (gray bars). Mice in which MYC was overexpressed during embryonic development developed liver tumors by 2 d of age and exhibited MYC RNA levels similar to those observed in neonatal and adult tumors (white bars).
###end p 180
###begin title 181
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation during Embryonic Development Induces a Rapid Onset of Neoplasia
###end title 181
###begin p 182
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(A) A normal neonatal liver and a neonatal liver in which MYC was activated embryonically.
###end p 182
###begin p 183
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(B) Histology of a normal neonatal liver in which MYC was not activated.
###end p 183
###begin p 184
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(C) Histology of a neonatal liver in which MYC was activated embryonically.
###end p 184
###begin p 185
(D) DNA content of normal neonatal hepatocytes.
###end p 185
###begin p 186
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(E) DNA content of neonatal hepatocytes in which MYC was activated embryonically.
###end p 186
###begin p 187
(F and H) Ki67 immunofluorescence and DAPI staining corresponding to a normal neonatal liver.
###end p 187
###begin p 188
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(G and I) Ki67 immunofluorescence and DAPI staining corresponding to a neonatal liver in which MYC was activated embryonically.
###end p 188
###begin title 189
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation in Adult Hepatocytes Causes Cellular Hypertrophy
###end title 189
###begin p 190
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
(A) Relative volumes of neonatal hepatocytes and nuclei after MYC activation. Data are expressed as normalized volume plus or minus the standard error of the mean. The volume was normalized by dividing each measurement by the mean volume of normal 1-d-old neonatal mice. Three livers were measured per time point. T, tumor.
###end p 190
###begin p 191
###xml 41 43 41 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MY</italic>
(B) Neonatal liver weights of normal and MYC-activated livers. Three to five livers were weighed per time point. Data are expressed as the mean weight (grams) plus or minus the standard error of the mean.
###end p 191
###begin p 192
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
(C) Relative volumes of adult hepatocytes and nuclei after MYC activation. Volumes of cells are expressed as the mean volume divided by the mean volume of hepatocytes from normal mice plus or minus the standard error of the mean. Cells from two to three livers were measured per time point.
###end p 192
###begin p 193
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(D) Adult liver weights after MYC activation. A total of nine livers were measured per time point after MYC activation. Data are expressed as the mean weight (grams) plus or minus the standard error of the mean.
###end p 193
###begin title 194
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation at Birth Induces Proliferation of Neonatal Hepatocytes
###end title 194
###begin p 195
(A) Histology of a normal 10-d-old neonatal liver.
###end p 195
###begin p 196
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(B) Histology of a 10-d-old liver in which MYC was activated at birth.
###end p 196
###begin p 197
(C) Histology of a normal 18-d-old neonatal liver.
###end p 197
###begin p 198
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(D) Histology of a MYC-induced neonatal liver tumor that developed after 18 d of MYC overexpression; MYC was activated at birth.
###end p 198
###begin p 199
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
(E-L) Ki67 immunofluorescence (E-H) and DAPI staining (I-L) of normal neonatal hepatocytes (E, G, I, and K), MYC-activated hepatocytes (F and J), and MYC-induced neonatal tumors (H and L). Upon initial MYC activation in neonatal mice, there was a small increase in Ki67-positive cells. MYC-induced neonatal tumors exhibited much higher levels of Ki67-positive cells.
###end p 199
###begin title 200
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation in Adult Hepatocytes Induces Increased Cell Size and Endoreduplication, and Only Results in Cell Proliferation upon Neoplastic Conversion of Hepatocytes
###end title 200
###begin p 201
(A) Histology of a normal liver.
###end p 201
###begin p 202
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(B) Histology of a liver 2 months after MYC activation.
###end p 202
###begin p 203
(C) Histology of a MYC-induced liver tumor.
###end p 203
###begin p 204
(D and G) Ki67 immunofluorescence and DAPI staining of a normal adult liver.
###end p 204
###begin p 205
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(E and H) Ki67 and DAPI staining of an adult liver after 8 weeks of MYC activation.
###end p 205
###begin p 206
(F and I) Ki67 and DAPI staining of a MYC-induced adult tumor.
###end p 206
###begin p 207
(J) DNA content measured in normal hepatocytes.
###end p 207
###begin p 208
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(K) DNA content measured after MYC induction for 2 months.
###end p 208
###begin p 209
(L) DNA content of a representative MYC-induced liver tumor.
###end p 209
###begin title 210
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation in Adult Hepatocytes Induces Increased Cell Size
###end title 210
###begin p 211
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
A histogram obtained by FACS forward versus light scatter analysis of adult hepatocytes from normal FVB/N livers (green), doxycycline-treated transgenic livers (red), and livers in which the MYC transgene was overexpressed for 3 months (blue). The x-axis represents cell size and the y-axis represents cell count. Adult mice were matched for age.
###end p 211
###begin title 212
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 44 50 <span type="species:ncbi:10090">Murine</span>
MYC Activation Does Not Induce Apoptosis in Murine Hepatocytes
###end title 212
###begin p 213
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
TUNEL assay (A, C, E, G, and I) and DAPI staining (B, D, F, H, and J) of normal (A, B, E, and F) and MYC-activated (C, D, and G-J) hepatocytes of neonatal (A-D) and adult (E-J) mice. After 4 weeks of MYC activation in adult hepatocytes, there was no evidence of apoptosis either by TUNEL assay (G) or by DAPI staining of nuclei (H). MYC activation is associated with increased apoptosis with the neoplastic conversion of neonatal (C) and adult (I) hepatocytes. Representative data from one of three experiments are shown. Identical results were seen when MYC was activated for 2 or 8 weeks.
###end p 213
###begin title 214
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MYC Activation Induces p53 Function, and Loss of p53 Function Is Necessary for MYC to Induce Tumorigenesis in Adult Hepatocytes
###end title 214
###begin p 215
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
(A) Western blot analysis for p53 protein expression after MYC activation for 1 month, 2 months, and in MYC-induced tumors. As a positive control, we used a lymphoma cell line that overexpresses a mutant p53, kindly provided by Dr. Kevin Smith.
###end p 215
###begin p 216
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
(B) Western blot analysis for p53 protein expression in a normal neonatal liver, in a neonatal liver in which MYC was activated during embryonic development that was obtained from a 2-d-old mouse, and in MYC-induced neonatal tumors. As a positive control, we used a lymphoma cell line generated in our lab that overexpresses a mutant p53.
###end p 216
###begin p 217
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM2</italic>
(C) Northern blot analysis for p21 and MDM2 in neonatal and adult liver tumors.
###end p 217
###begin p 218
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
(D) Survival of adult mice after activation of MYC in the presence of the wild type or the loss of one p53 allele.
###end p 218
###begin p 219
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 39 49 39 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC/p53<sup>+/&#8722;</sup></italic>
(E) Loss of heterozygosity analysis of MYC/p53+/- tumors by PCR analysis.
###end p 219
###begin title 220
###xml 74 78 <span type="species:ncbi:10090">Mice</span>
Partial Hepatectomy Accelerates the Ability of MYC to Induce HCC in Adult Mice
###end title 220
###begin p 221
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
(A) Liver from an adult mouse 7 weeks after MYC activation exhibited no gross phenotypic changes (left), whereas the liver from an adult mouse 7 weeks after MYC activation that had undergone partial hepatectomy exhibited a multifocal liver tumor (right).
###end p 221
###begin p 222
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
(B) The histology of the liver from an adult mouse 7 weeks after MYC activation exhibited no evidence of a tumor.
###end p 222
###begin p 223
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
(C) The histology of a liver from an adult mouse after MYC activation that had undergone partial hepatectomy exhibited a multifocal HCC.
###end p 223
###begin p 224
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
(D) Survival after MYC activation in adult mice that have either not undergone surgery (blacksquare, square, filled) or undergone a partial hepatectomy (square). Results are pooled from two independent experiments with a total of ten mice per group.
###end p 224
###begin p 225
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflicts of interest.</bold>
Conflicts of interest. The authors have declared that no conflicts of interest exist.
###end p 225
###begin p 226
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. SB and DWF conceived and designed the experiments. SB, AZ, RAI, RAM, QY, NB, CA, LDA, SF, and DWF performed the experiments. SB, BR, RDC, and DWF analyzed the data. RAM, CA, LDA, BR, RDC, and DWF contributed reagents/materials/analysis tools. SB and DWF wrote the paper.
###end p 226
###begin p 227
###xml 38 43 <span type="species:ncbi:9606">Human</span>
Academic Editor: Nicholas Hastie, MRC Human Genetics Unit, Western General Hospital
###end p 227
###begin p 228
Citation: Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, et al. (2004) Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol 2(11): e332.
###end p 228

